Division of Neonatology, The Affiliated Hospital of Qingdao University, Shandong, China.
Division of Neonatology, Beijing jingdu Children's Hospital, Beijing, China.
BMC Pediatr. 2024 Feb 12;24(1):107. doi: 10.1186/s12887-024-04556-x.
As the predominant complication in preterm infants, Bronchopulmonary Dysplasia (BPD) necessitates accurate identification of infants at risk and expedited therapeutic interventions for an improved prognosis. This study evaluates the potential of Monosaccharide Composite (MC) enriched with environmental information from circulating glycans as a diagnostic biomarker for early-onset BPD, and, concurrently, appraises BPD risk in premature neonates.
The study incorporated 234 neonates of ≤32 weeks gestational age. Clinical data and serum samples, collected one week post-birth, were meticulously assessed. The quantification of serum-free monosaccharides and their degraded counterparts was accomplished via High-performance Liquid Chromatography (HPLC). Logistic regression analysis facilitated the construction of models for early BPD diagnosis. The diagnostic potential of various monosaccharides for BPD was determined using Receiver Operating Characteristic (ROC) curves, integrating clinical data for enhanced diagnostic precision, and evaluated by the Area Under the Curve (AUC).
Among the 234 neonates deemed eligible, BPD development was noted in 68 (29.06%), with 70.59% mild (48/68) and 29.41% moderate-severe (20/68) cases. Multivariate analysis delineated several significant risk factors for BPD, including gestational age, birth weight, duration of both invasive mechanical and non-invasive ventilation, Patent Ductus Arteriosus (PDA), pregnancy-induced hypertension, and concentrations of two free monosaccharides (Glc-F and Man-F) and five degraded monosaccharides (Fuc-D, GalN-D, Glc-D, and Man-D). Notably, the concentrations of Glc-D and Fuc-D in the moderate-to-severe BPD group were significantly diminished relative to the mild BPD group. A potent predictive capability for BPD development was exhibited by the conjunction of gestational age and Fuc-D, with an AUC of 0.96.
A predictive model harnessing the power of gestational age and Fuc-D demonstrates promising efficacy in foretelling BPD development with high sensitivity (95.0%) and specificity (94.81%), potentially enabling timely intervention and improved neonatal outcomes.
支气管肺发育不良(BPD)是早产儿的主要并发症,因此需要准确识别有风险的婴儿,并尽快进行治疗干预,以改善预后。本研究评估了富含循环糖中环境信息的单糖复合物(MC)作为早期 BPD 诊断生物标志物的潜力,并同时评估了早产儿患 BPD 的风险。
该研究纳入了 234 名胎龄≤32 周的新生儿。仔细评估了出生后一周采集的临床数据和血清样本。通过高效液相色谱法(HPLC)定量测定血清游离单糖及其降解产物。使用逻辑回归分析构建早期 BPD 诊断模型。使用接收者操作特征(ROC)曲线确定各种单糖对 BPD 的诊断潜力,结合临床数据以提高诊断精度,并通过曲线下面积(AUC)进行评估。
在 234 名符合条件的新生儿中,有 68 名(29.06%)发生了 BPD,其中 70.59%为轻度(48/68),29.41%为中重度(20/68)。多变量分析确定了 BPD 的几个显著风险因素,包括胎龄、出生体重、有创机械通气和无创通气的持续时间、动脉导管未闭(PDA)、妊娠高血压和两种游离单糖(Glc-F 和 Man-F)和五种降解单糖(Fuc-D、GalN-D、Glc-D 和 Man-D)的浓度。值得注意的是,中重度 BPD 组的 Glc-D 和 Fuc-D 浓度明显低于轻度 BPD 组。胎龄和 Fuc-D 的联合具有很高的预测能力,AUC 为 0.96。
利用胎龄和 Fuc-D 的预测模型在预测 BPD 发展方面具有很高的敏感性(95.0%)和特异性(94.81%),具有很高的应用潜力,可以及时进行干预,改善新生儿预后。